Abstract
Approximately 2.4 million patients in Japan need treatment for thyroid disease, including Graves’ disease and Hashimoto’s disease. However, only 450,000 of them are receiving treatment, and many patients with thyroid dysfunction remain largely overlooked. In this retrospective study, we aimed to screen patients with hyperthyroidism and hypothyroidism who would greatly benefit from prompt medical treatment. We examined routine laboratory finding data and machine learning algorithms to investigate whether such accurate and robust screening is possible to prevent overlooking and misdiagnosing thyroid dysfunction. We succeeded in developing a machine learning method to construct a classification model for detecting hyperthyroidism and hypothyroidism in patients using 11 routine laboratory tests. We collected electronic health records and medical checkup data from four hospitals in Japan. As a result of cross-validation and external evaluation, we achieved a high classification accuracy for the hyperthyroidism and hypothyroidism models.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The institutional ethical review boards of the three institutions at which the study was conducted gave their approval (Approval Number of Wakayama Medical University Hospital: 2301, Hidaka Hospital: 257, Gunma University Hospital : HS2018-245)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Figure 2 and Table 3 revised. Sections on code availability updated.
Data Availability
The data that support the findings of this study are available from Japan Thyroid Association but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of Japan Thyroid Association.